Quantcast

Latest Alcohols Stories

2014-03-27 08:33:49

Cardiome to conduct conference call and webcast today, March 27, at 8:00 a.m. Eastern (5:00 a.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER, March 27, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for the fourth quarter and year ended December 31, 2013. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States (U.S. GAAP)....

2014-03-27 08:33:37

Ashfield Market Access to provide managed markets and trade support RALEIGH, N.C., March 27, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has entered into an agreement with Quintiles to provide a range of services to support the anticipated launch of BUNAVAIL (buprenorphine and naloxone buccal film), BDSI's proposed maintenance treatment for opioid dependence. BUNAVAIL is currently under review at the U.S. Food and Drug...

2014-03-26 16:24:39

DUBLIN, Mar. 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3zhmm6/global ) has announced the addition of the "Global Intravenous Solutions Market 2014-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Intravenous Vitamin C therapy has been shown to be effective against a wide variety of cancers. By intravenously injecting Vitamin C into a patient, it was observed that Ascorbate was able to generate a...

2014-03-26 08:28:21

SILVER SPRING, Md., March 26, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin(®) (treprostinil) Injection for the treatment of pulmonary arterial hypertension (PAH) by subcutaneous and intravenous administration. Remodulin will be sold in Japan under the brand name Treprost(TM) by Mochida Pharmaceutical Co., Ltd., under an exclusive distribution agreement with...

2014-03-26 08:23:34

Management to Detail the Commercialization of High Value Pain Products including Oxycodone using its TPM® Topical Drug Delivery Technology MELBOURNE, Australia, March 26, 2014 /PRNewswire/ --Phosphagenics Limited (ASX: POH) (OTCQX: PPGNY) ("Phosphagenics" or "the Company") announced today that management will host an investor conference call and webcast to discuss the commercial opportunities arising from a range of innovative analgesic products emerging from the Company's...

2014-03-25 16:27:10

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qs69zd/survey_of_feed) has announced the addition of the "Survey of Feed Pigments in China" [http://www.researchandmarkets.com/research/qs69zd/survey_of_feed ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The feed pigment industry in China has witnessed two obvious changes in the past decade: natural products are...

2014-03-25 04:20:37

HUNTINGTON, N.Y., March 25, 2014 /PRNewswire/ -- VisiVite®, a world leader in eye vitamins, today announced its launch of a gentle new macular health formula: AREDS2 Silver®. Based on the National Eye Institute's Age-Related Eye Disease Studies (AREDS and AREDS2), AREDS2 Silver supplies antioxidants for macular health without the high levels of zinc that may cause issues in those with zinc sensitivities and allergies. http://photos.prnewswire.com/prnvar/20140325/NY87258 The first AREDS...

Researchers Discover Underlying Genetics Tied To Increased Risk For Stroke And Cardiovascular Disease
2014-03-21 10:26:43

NIH/National Human Genome Research Institute NIH-funded findings point to new potential strategies for disease prevention, treatment Scientists studying the genomes of nearly 5,000 people have pinpointed a genetic variant tied to an increased risk for stroke, and have also uncovered new details about an important metabolic pathway that plays a major role in several common diseases. Together, their findings may provide new clues to underlying genetic and biochemical influences in the...

2014-03-20 08:29:29

NASDAQ: CRME TSX: COM VANCOUVER, March 20, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report financial results for the fourth quarter and fiscal year ended December 31, 2013 on the morning of Thursday, March 27, 2014. Cardiome will hold a conference call and webcast at 8:00 a.m. Eastern (5:00 a.m. Pacific) on that day to discuss the results. To access the conference call, please dial 416-764-8688 or 888-390-0546 and use...

2014-03-19 08:28:39

NASDAQ: CRME TSX: COM VANCOUVER, March 19, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that the company has entered into a distribution agreement with Logista Pharma S.A., headquartered in Madrid, Spain, to distribute BRINAVESS(TM) (vernakalant IV) within the Spanish market. "We are pleased to have entered into this agreement with Logista Pharma to distribute BRINAVESS to our Spanish customers," said Karim Lalji, Cardiome's Chief...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related